Following a triple-digit million-euro investment to build a new biosurfactant plant in Slovakia, Evonik has launched the sustainable rhamnolipid REWOFERM® RL 100. The new biosurfactant meets demand from the cleaning… Read More
Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta The World Health Organization (WHO)… Read More
First and Only PARP Inhibitor to Demonstrate Overall Survival Benefit in Certain Patients With Early Breast Cancer, A Key Secondary Endpoint KENILWORTH, N.J.— AstraZeneca and Merck (NYSE: MRK), known as… Read More
Nimbus Synergies, investor, partner, and mentor to Canada’s leading health technology companies, is pleased to announce the completion of a $20 million strategic investment in Clarius Mobile Health. This new… Read More
Prestigious award recognizes SVB for demonstrating outstanding corporate citizenship SVB Financial Group (SVB), the financial partner of the innovation economy, has been recognized by the Foreign Policy Association (FPA) as… Read More
